A recent health report reveals the dangers of silent kidney damage, where individuals can lose up to <strong>80%</strong> of kidney function without any clear symptoms. This highlights the importance of early screening and detection of kidney issues.
Dr. Rohan Goyal, founder of the Novana Center in India, explains the differences between back pain caused by lifestyle and kidney-related pain. Understanding these distinctions can aid in early diagnosis and effective treatment.
A recent medical study reveals that deteriorating cardiovascular and kidney health, along with metabolic disorders, heightens the likelihood of cancer. These findings raise concerns about the link between chronic diseases and cancer risk.
The Malaysian Health Minister announced a significant rise in treatment costs for advanced chronic kidney disease, reaching <strong>3.3 billion ringgit</strong> annually. This surge coincides with an increase in disease cases, posing a substantial financial burden on the country.
Biogen, a company specializing in drug development, has announced its acquisition of Apellis Pharmaceuticals for <strong>$5.6 billion</strong>. This move aims to expand Biogen's capabilities in treating kidney diseases, addressing the growing need for effective therapies.
A discussion at the European Health Summit in Brussels revealed common delays in diagnosing rare kidney diseases, negatively impacting patients and their families. New data indicates that early diagnosis can alleviate health and economic burdens.